We are live on ! Find out more
MA

MYDA Advisors Portfolio holdings

AUM $608M
1-Year Est. Return 77.08%
This Fund
S&P 500
This Quarter Est. Return
+1.68%
1 Year Est. Return
+77.08%
3 Year Est. Return
+189.24%
5 Year Est. Return
+248.06%
10 Year Est. Return
–
AUM
$375M
AUM Growth
+$17.5M
Cap. Flow
+$27.1M
Cap. Flow %
7.23%
Top 10 Hldgs %
24.54%
Holding
378
New
118
Increased
38
Reduced
55
Closed
121

Top Buys

Rank Stock Value
1
ORCL icon
Oracle
ORCL
+$9.39M
2
NFLX icon
Netflix
NFLX
+$6.96M
3
BKNG icon
Booking.com
BKNG
+$6.16M
4
DIS icon
Walt Disney
DIS
+$5.65M
5
MACUU
Mallard Acquisition Corp. Unit
MACUU
+$4.6M

Top Sells

Rank Stock Value
1
BZFD icon
BuzzFeed
BZFD
+$9.91M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$5.1M
3
MACU
Mallard Acquisition Corp. Common stock
MACU
+$4.48M
4
STVN icon
Stevanato
STVN
+$3.29M
5
NOAC
Natural Order Acquisition Corp. Common Stock
NOAC
+$3.15M

Sector Composition

Rank Sector Weight
1 Financials 23.55%
2 Communication Services 10.83%
3 Technology 10.48%
4 Consumer Discretionary 9.82%
5 Industrials 6.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CND
201
DELISTED
Concord Acquisition Corp.
CND
$208K 0.06%
20,000
+4,121
+26% +$45.1K
CND.WS
202
DELISTED
Concord Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
CND.WS
$201K 0.05%
74,538
+34,538
+86% +$89.2K
OACB
203
DELISTED
Oaktree Acquisition Corp. II
OACB
$198K 0.05%
+20,017
New +$198K
TPGY
204
DELISTED
TPG Pace Beneficial Finance Corp.
TPGY
$196K 0.05%
+20,000
New +$210K
ASLN
205
DELISTED
ASLAN Pharmaceuticals Limited American Depositary Shares
ASLN
$190K 0.05%
4,250
-1,654
-28% -$99.2K
BMTX.WS
206
DELISTED
BM Technologies, Inc. Warrants, each warrant exercisable for one share of Common Stock at an exercise price of $11.50
BMTX.WS
$172K 0.05%
92,000
-24,870
-21% -$49.9K
NUVB icon
207
Nuvation Bio
NUVB
$2.24B
$170K 0.05%
20,000
-20,000
-50% -$184K
EQRX
208
DELISTED
EQRx, Inc. Common Stock
EQRX
$136K 0.04%
+20,000
New +$189K
IMTX icon
209
Immatics
IMTX
$1.24B
$134K 0.04%
10,000
– –
NOACW
210
DELISTED
Natural Order Acquisition Corp. Warrant
NOACW
$126K 0.03%
300,360
-20,000
-6% -$10.1K
LIAN
211
DELISTED
LianBio American Depositary Shares
LIAN
$123K 0.03%
+20,000
New +$228K
RKLY.WS
212
DELISTED
Rockley Photonics Holdings Limited Warrants, each warrant exercisable for one ordinary share at an exercise price of $11.50
RKLY.WS
$121K 0.03%
100,000
– –
RKDA icon
213
Arcadia Biosciences
RKDA
$1.4M
$104K 0.03%
2,503
+1,001
+67% +$65.3K
LAAAW
214
DELISTED
Lakeshore Acquisition I Corp. Warrant
LAAAW
$101K 0.03%
131,250
– –
OWL.WS
215
DELISTED
Blue Owl Capital Inc. Redeemable Warrants, each whole warrant exercisable for one share of Class A C
OWL.WS
$101K 0.03%
21,562
-2,801
-11% -$14.4K
VATE icon
216
INNOVATE Corp
VATE
$114M
$99K 0.03%
+2,678
New +$106K
APGB
217
DELISTED
Apollo Strategic Growth Capital II
APGB
$99K 0.03%
+10,000
New +$97.8K
NXDR
218
Nextdoor Holdings
NXDR
$835M
$95K 0.03%
12,000
-90,392
-88% -$933K
BTWNW
219
DELISTED
Bridgetown Holdings Limited Warrants
BTWNW
$80K 0.02%
90,000
– –
MKTWW
220
DELISTED
MarketWise, Inc. Warrant
MKTWW
$80K 0.02%
84,000
+50,000
+147% +$55.6K
FLACW
221
DELISTED
Frazier Lifesciences Acquisition Corporation Warrant
FLACW
$77K 0.02%
129,800
-200
-0.2% -$140
MBAC.WS
222
DELISTED
M3-Brigade Acquisition II Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
MBAC.WS
$77K 0.02%
66,350
+41,350
+165% +$54.8K
NUVB.WS
223
DELISTED
Nuvation Bio Inc Warrants
NUVB.WS
$72K 0.02%
38,000
– –
NXU.WS
224
DELISTED
Novus Capital Corporation II Redeemable warrants, each whole warrant exercisable for shares of Class
NXU.WS
$64K 0.02%
50,996
– –
TLSIW icon
225
TriSalus Life Sciences Warrant
TLSIW
$25.5M
$62K 0.02%
119,800
– –
7 8
9
10 11

Similar funds

KJHP
K.J. Harrison & Partners Toronto, Ontario, Canada $608M AUM 45.31% 1-Year Est. Return
NFSG
Newbridge Financial Services Group Boca Raton, Florida $608M AUM 31.28% 1-Year Est. Return
AAM
Austin Asset Management Austin, Texas $608M AUM 18.68% 1-Year Est. Return
FSC
Fourth Sail Capital Camana Bay Grand Cayman, Cayman Islands $608M AUM 48.69% 1-Year Est. Return
EFG
Everest Financial Group Minneapolis, Minnesota $607M AUM
OWM
Opes Wealth Management Menlo Park, California $609M AUM 20.17% 1-Year Est. Return
AFG
Altiora Financial Group Lebanon, Ohio $607M AUM 12.43% 1-Year Est. Return
AIG
American International Group New York $609M AUM 23.67% 1-Year Est. Return

MYDA Advisors's Q4 2021 Portfolio in Review

As of Q4 2021, MYDA Advisors held 378 positions worth $375M, up 4.9% from $357M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

MYDA Advisors deployed $27.1M of net new capital in Q4 2021, opening 118 new positions and adding to 38 existing holdings. Its largest new stake was Oracle: 100,000 shares worth $8.72M.

By sector, the portfolio is most concentrated in Financials at 24% of assets, down from 24% a quarter earlier, followed by Communication Services and Technology.

On the sell side, the largest reduction was Regeneron Pharmaceuticals, an estimated $5.1M trimmed.

  • MYDA Advisors's largest Q4 2021 buy was Oracle: 100,000 shares worth $8.72M.
  • MYDA Advisors added most to Netflix in Q4 2021, an estimated $6.96M increase.
  • MYDA Advisors's biggest Q4 2021 reduction was Regeneron Pharmaceuticals, cutting an estimated $5.1M.
  • MYDA Advisors fully exited BuzzFeed in Q4 2021, selling an estimated $9.91M.
  • MYDA Advisors's ten largest holdings make up 25% of its $375M portfolio in Q4 2021.
  • MYDA Advisors opened 118 new positions and closed 121 in Q4 2021.
  • MYDA Advisors's portfolio value rose 4.9% quarter-over-quarter to $375M.

Based on MYDA Advisors's 13F filing for Q4 2021, filed 11 Feb 2022.